1. Perioperative management for geriatric patients with dementia
   Hitoshi NIWA, 2019, Japanese Journal of Oral and Maxillofacial Surgery CrossRef
2. Yokukansan for perioperative psychiatric symptoms in cancer patients undergoing high invasive surgery. J-SUPPORT 1605 (ProD Study): study protocol for a randomized controlled trial
   Saho Wada et al, 2019, Trials CrossRef
3. Yokukansan for Treatment of Preoperative Anxiety and Prevention of Postoperative Delirium in Cancer Patients Undergoing Highly Invasive Surgery. J-SUPPORT 1605 (ProD Study): A Randomized, Double-Blind, Placebo-Controlled Trial
   Saho Wada et al, 2021, Journal of Pain and Symptom Management CrossRef
4. 抑肝散，抑肝散加陳皮半夏による周術期管理へのサポート
   育夫 中村 et al, 2022, The Japanese Journal of SURGICAL METABOLISM and NUTRITION CrossRef
5. Risk factors for postoperative delirium after gastrointestinal surgery - using randomized Phase II trial data
   Mariko Kamiya et al, 2018, Annals of Cancer Research and Therapy CrossRef
6. Pharmacologic interventions for prevention of delirium in hospitalized older people: A meta-analysis
   Beatriz León-Salas et al, 2020, Archives of Gerontology and Geriatrics CrossRef
7. Preoperative Risk Factors Associated with Increased Incidence of Postoperative Delirium: Systematic Review of Qualified Clinical Studies
   Vlasios Karageorgos et al, 2023, Geriatrics CrossRef
8. Risk Factors for Pseudoaldosteronism with Yokukansan Use: Analysis Using the Japanese Adverse Drug Report (JADER) Database
   Tomoaki Ishida et al, 2020, Biological and Pharmaceutical Bulletin CrossRef
9. Where should patients with or at risk of delirium be treated in an acute care system? Comparing the rates of delirium in patients receiving usual care vs alternative care: A systematic review and meta‐analysis
   Chinenye Ukwuoma Ekeozor et al, 2021, International Journal of Clinical Practice CrossRef
10. A Prospective Randomized Study of the Herbal Medicine Yokukansan for Preventing Delirium After Gastrointestinal Cancer Surgery
    Akimitsu Tanio et al, 2023, Yonago Acta Medica CrossRef
11. Yokukansan suppresses neuroinflammation in the hippocampus of mice and decreases the duration of lipopolysaccharide- and diazepam-mediated loss of righting reflex induced by pentobarbital
    Kei Kawada et al, 2022, Journal of Natural Medicines CrossRef
12. Pharmacological Prevention of Postoperative Delirium: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Yong Liu et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef
13. Yokukansan (TJ-54) in patients undergoing surgery: A systematic review and meta-analysis
    Kazumasa Kotake et al, 2023, Geriatric Nursing CrossRef
14. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Postoperative Delirium Prevention
    Christopher G. Hughes et al, 2020, Anesthesia & Analgesia CrossRef
15. Risk factor analysis of the postoperative delirium using randomized phase II trial data
    Toru Aoyama et al, 2018, Annals of Cancer Research and Therapy CrossRef
16. Pharmacological strategies to prevent postoperative delirium: a systematic review and network meta-analysis
    Jun Mo Lee et al, 2021, Anesthesia and Pain Medicine CrossRef
17. Impact of Gut Microbiota on the Pharmacokinetics of Glycyrrhizic Acid in Yokukansan, a Kampo Medicine
    Tomoaki Ishida et al, 2022, Biological and Pharmaceutical Bulletin CrossRef
18. Effectiveness and safety of the co‐administration of Yokukan‐San (Japanese herbal medicine) with antipsychotics in hospitalized older patients with pneumonia
    Akira Yokoyama et al, 2023, Geriatrics & Gerontology International CrossRef
19. Multicomponent Interventions for the Prevention of Delirium in Hospitalized Older People: A Meta‐Analysis
    Beatriz León‐Salas et al, 2020, Journal of the American Geriatrics Society CrossRef